Rchr
J-GLOBAL ID:202101013552555358   Update date: Mar. 01, 2024

Taniki Nobuhito

タニキ ノブヒト | Taniki Nobuhito
Affiliation and department:
Research theme for competitive and other funds  (4):
  • 2022 - 2025 ”腸-肝臓-脳相関”で構成される自律神経回路による大腸癌の新規病態解明と治療開発
  • 2020 - 2022 Development of a new treatment for primary sclerosing cholangitis with indigo naturalis
  • 2018 - 2020 Mechanism of immune tolerance in the liver via gut-liver axis
  • 2016 - 2019 Role of gut microbiota in the pathogenesis of primly sclerosing cholangitis
Papers (47):
  • 安藤 裕子, 中代 幸江, 楮 柏松, 杉本 真也, 山田 洋平, 長谷川 康, 春日 良介, 田淵 貴也, 近藤 まゆ子, 森川 麗, et al. COVID-19を契機にAcute-on-chronic肝不全(ACLF)の回復期にGLP-2アナログを導入した腸管機能不全関連肝障害(IFALD)の一例. 肝臓. 2023. 64. Suppl.3. A911-A911
  • Sota Fujimori, Po-Sung Chu, Toshiaki Teratani, Yosuke Harada, Takahiro Suzuki, Takeru Amiya, Nobuhito Taniki, Ryosuke Kasuga, Yohei Mikami, Yuzo Koda, et al. IL-15-producing splenic B cells play pathogenic roles in the development of autoimmune hepatitis. JHEP Reports. 2023. 5. 7. 100757-100757
  • Masataka Ichikawa, Nobuhiro Nakamoto, Sharon Kredo-Russo, Eyal Weinstock, Iddo Nadav Weiner, Efrat Khabra, Noa Ben-Ishai, Dana Inbar, Noga Kowalsman, Ron Mordoch, et al. Bacteriophage therapy against pathological Klebsiella pneumoniae ameliorates the course of primary sclerosing cholangitis. Nature Communications. 2023. 14. 1. 3261-3261
  • Yoichi Takimoto, Po-Sung Chu, Nobuhiro Nakamoto, Yuya Hagihara, Yohei Mikami, Kentaro Miyamoto, Rei Morikawa, Toshiaki Teratani, Nobuhito Taniki, Sota Fujimori, et al. Myeloid TLR4 signaling promotes post-injury withdrawal resolution of murine liver fibrosis. iScience. 2023. 26. 3. 106220-106220
  • 近藤 まゆ子, 谷木 信仁, 中代 幸江, 春日 良介, 田淵 貴也, 野口 二三枝, 山高 果林, 森川 麗, 尾城 啓輔, チョ 柏松, et al. 免疫関連有害事象による二次性硬化性胆管炎の臨床経験. 日本消化器病学会雑誌. 2023. 120. 臨増総会. A413-A413
more...
MISC (149):
  • Ryosuke Kasuga, Po-Sung Chu, Nobuhito Taniki, Nobuhiro Nakamoto, Takanori Kanai. SERUM ALBUMIN LEVELS IMPROVE TRANSPLANT-FREE SURVIVAL PREDICTING PERFORMANCE OF CLIF-C ACLF SCORES IN CIRRHOTIC PATIENTS SUFFERED FROM AD/ACLF BEYOND 90 DAYS. HEPATOLOGY. 2022. 76. S914-S915
  • Nobuhito Taniki, Ryosuke Kasuga, Po-Sung Chu, Akihiro Yamaguchi, Hitomi Hoshi, Keisuke Ojiro, Fumihiko Kaneko, Nobuhiro Nakamoto, Takanori Kanai. PRIOR HISTORY OF LOCOREGIONAL THERAPY ASSOCIATES WITH TACE REFRACTORINESS IN PATIENTS WITH INTERMEDIATE STAGE HEPATOCELLULAR CARCINOMA. HEPATOLOGY. 2022. 76. S1403-S1403
  • 岩崎栄典, 谷木信仁, 堀周太郎, 曽我茂樹. Percutaneous transhepatic gallbladder drainage for acute cholecystitis. 肝胆膵. 2022. 85. 4. 543-550
  • 谷木 信仁, 中本 伸宏, 金井 隆典. 肝癌局所療法の成績向上に向けた取り組み 新規マイクロ波アブレーション(MWA)の治療成績向上に向けた取り組み. 肝臓. 2022. 63. Suppl.3. A717-A717
  • 肱岡 悠子, 戸張 真紀, 永松 洋明, 丸山 紀史, 黒田 英克, 畑中 健, 小宮山 泰之, 堀田 直樹, 谷木 信仁, 吉田 英雄, et al. 肝細胞癌患者を対象としたマイクロ波焼灼術とラジオ波焼灼術の有効性,安全性に関する検討. 肝臓. 2022. 63. Suppl.3. A754-A754
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page